Resistance to antimicrobials and vancomycin treatment in neonatal sepsis in a hospital in Brazil

Rafael H.  SILVEIRA; Kelly G.  LIMA; Carolina H.  SANTOS-BOROWICZ; Karin H.  SCHWAMBACH; Hugo  BOCK

doi:10.30968/rbfhss.2020.113.0472

Resistance to antimicrobials and vancomycin treatment in neonatal sepsis in a hospital in Brazil

Authors

Rafael H. SILVEIRA
Kelly G. LIMA https://orcid.org/0000-0002-1912-2150
Carolina H. SANTOS-BOROWICZ
Karin H. SCHWAMBACH https://orcid.org/0000-0003-3271-2566
Hugo BOCK https://orcid.org/0000-0002-1994-5210

DOI:

https://doi.org/10.30968/rbfhss.2020.113.0472

Abstract

Objective: To describe the antimicrobial resistance profile of strains isolated from neonates with septicemia undergoing vancomycin treatment, to determine the agreement of treatment with guideline and blood cultures, to assess the presence of acute kidney injury (AKI) and the clinical outcome in a hospital in Brazil. Methods: A total of 51 newborns treated with vancomycin were studied in the period from January to December 2017. Treatment assessment was verified by the compliance with the Rational Use and Insurance Policy of Antibiotics in Neonatology and blood culture. The presence of AKI was based on the results of serum creatinine. The data were monitored by the computerized system of the laboratory. Results: The main isolated strain was Staphylococcus (coagulase negative) (82.9%), 93.5% with resistance to oxacillin for early infections and 100% for late infections. The same strain showed 54.8% resistance to gentamicin for cases of early sepsis and 66.6% for late sepsis. There were no cases of resistance to vancomycin. The treatments agreed with the reference protocol in 46.3% and with the results of blood cultures in 56%. Only two cases of AKI are observed. Conclusions: The oxacillin-resistant coagulase-negative staphylococcus strains were the main causes of neonatal sepsis. The use of gentamicin for sensitive strains may reduce the use of vancomycin. The results suggest the need for better standardization of the treatment to reduce the risk of toxicity and rational use of therapeutic resources.

Downloads

Download data is not yet available.

Downloads

Published

2020-09-21

How to Cite

SILVEIRA RH, LIMA KG, SANTOS-BOROWICZ CH, SCHWAMBACH KH, BOCK H. Resistance to antimicrobials and vancomycin treatment in neonatal sepsis in a hospital in Brazil. Rev Bras Farm Hosp Serv Saude [Internet]. 2020Sep.21 [cited 2024Nov.22];11(3):472. Available from: https://rbfhss.org.br/sbrafh/article/view/472

Download Citation

Issue

Vol. 11 No. 3 (2020): Jul-Sep

Section

ORIGINAL ARTICLES

License

The authors hereby transfer, assign, or otherwise convey to RBFHSS: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print republish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to RHFHSS with this document.

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Serlf-archiving policy

This journal permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.